Head and Neck squamous cell carcinoma
Conditions
Interventions
Group with necrotic metastatic neck nodes:NA
Sponsors
Eye & ENT Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: (1) The patient has signed the informed consent form and voluntarily joined this study; (2) Pathological diagnosis of head and neck squamous cell carcinoma; (3) Age: >= 18 years old. (4) Gender is not limited to men or women. (5) Liver and kidney function and blood routine are basically normal, including: liver function: serum alanine aminotransferase and alanine aminotransferase 60 ml/(min * 1.73m^2). Blood cells: neutrophil count >= 1.5 * 10^9, platelet count >= 100 * 10^9, hemoglobin >= 90g/l. (6) Imaging confirms the presence of lymph node metastasis. (7) Primary lesion staging is not limited (8) Expected good compliance.
Exclusion criteria
Exclusion criteria: (1) Currently participating in other clinical studies, and for participants who have previously participated in drug clinical trials, the interval from the last medication should be more than one month. (2) Patients with serious organ system diseases such as cardiovascular, digestive, urinary, and nervous system disorders, or severe acute and chronic medical conditions such as uncontrollable systemic infections, as well as mental illnesses (including recent [past year] or active suicidal ideation or behavior), who have been assessed by researchers as unsuitable for participation in this clinical study. (3) Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sequencing analysis results; | — |
Secondary
| Measure | Time frame |
|---|---|
| clinical data;3-year disease-free survival time;3-year overall survival time;3-year cancer control rate;Tumor regression rate after induction chemotherapy;adverse reactions rate; | — |
Countries
China
Contacts
Public ContactMing Zhang
Eye & ENT Hospital, Fudan University
Outcome results
None listed